More Senate questions for Henney
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner-nominee Jane Henney, MD, is asked to provide her "general understanding" of FDA's policy regarding advertising and promoting laser-assisted in situ keratomileusis (LASIK) procedures with unapproved "black box" lasers and approved lasers. The question is one of 24 submitted to the nominee on Oct. 1 by Sen. Orrin Hatch (R-Utah.), who also asks Henney whether it would be in the interest of "public health if an [over-the-counter] home drug analysis test kit came on the market." In addition to the questions, Hatch requests a meeting with Henney to discuss her responses, the need for which could postpone the Senate's consideration of the nomination past the target adjournment date of Oct. 9